Clinical Trials
26 trialsMultitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
National Institutes of Health Clinical Center (CC)
AAPICO
Centre Hospitalier Departemental Vendee
iCCaRE
University of Ilorin Teaching Hospital
Lutécio
Instituto do Cancer do Estado de São Paulo
MOMENT
Prostate Cancer Clinical Trials Consortium
ChefHat-001
BigHat Biosciences, Inc.
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
MIDAS-SBRT
University Health Network, Toronto
Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma
Fudan University
ACCESS-PC
Rutgers, The State University of New Jersey
Endeavor-2
University Hospital, Antwerp
Rezvilutamide for High-Risk Prostate Cancer After Surgery
Fujian Medical University Union Hospital
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer
Erasmus Medical Center
A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
Antelope Surgical Solutions, Inc
CONVERT-HB1
Fudan University
A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers
Novartis
NACRE-2
UNICANCER
Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Qilu Pharmaceutical Co., Ltd.
PROSTIA- BP
Central Hospital, Nancy, France
Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial
East and North Hertfordshire NHS Trust
PCS-XII
Charles LeMoyne Hospital
URO-ROBOT-2023
IRCCS Azienda Ospedaliero-Universitaria di Bologna
TRACE
Shanghai Chest Hospital
Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study
The First People's Hospital of Changzhou
Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer
Ruijin Hospital